Artificial intelligence differentiates abdominal Henoch‐Schönlein purpura from acute appendicitis in children
Authors:
- 31 October 2023
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 26 (12) , 2534-2542
Abstract
Objective: This study aims to construct an artificial intelligence (AI) model capable of effectively discriminating between abdominal Henoch‐Schönlein purpura (AHSP) and acute appendicitis (AA) in pediatric patients.Methods: A total of 6965 participants, comprising 2201 individuals with AHSP and 4764 patients with AA, were enrolled in the study. Additionally, 53 laboratory indicators were taken into consideration. Five distinct artificial intelligence (AI) models were developed employing machine learning algorithms, namely XGBoost, AdaBoost, Gaussian Naïve Bayes (GNB), MLPClassifier (MLP), and support vector machine (SVM). The performance of these prediction models was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve assessment, and decision curve analysis (DCA).Results: We identified 32 discriminative indicators (p < .05) between AHSP and AA. Five indicators, namely the lymphocyte ratio (LYMPH ratio), eosinophil ratio (EO ratio), eosinophil count (EO count), neutrophil ratio (NEUT ratio), and C‐reactive protein (CRP), exhibited strong performance in distinguishing AHSP from AA (AUC ≥ 0.80). Among the various prediction models, the XGBoost model displayed superior performance evidenced by the highest AUC (XGBoost = 0.895, other models < 0.89), accuracy (XGBoost = 0.824, other models < 0.81), and Kappa value (XGBoost = 0.621, other models < 0.60) in the validation set. After optimization, the XGBoost model demonstrated remarkable diagnostic performance for AHSP and AA (AUC > 0.95). Both the calibration curve and decision curve analysis suggested the promising clinical utility and net benefits of the XGBoost model.Conclusion: The AI‐based machine learning model exhibits high prediction accuracy and can differentiate AHSP and AA from a data‐driven perspective.Keywords
Funding Information
- National Natural Science Foundation of China (82203493, 81960101)
- Fundamental Research Funds for the Central Universities (3012300076)
This publication has 27 references indexed in Scilit:
- High-performance medicine: the convergence of human and artificial intelligenceNature Medicine, 2019
- Artificial intelligence in healthcareNature Biomedical Engineering, 2018
- Protecting Your Patients’ Interests in the Era of Big Data, Artificial Intelligence, and Predictive AnalyticsJournal of the American College of Radiology, 2018
- Diagnosis of acute pediatric appendicitis from children with inflammatory diseases by combination of metabolic markers and inflammatory response variablesClinical Chemistry and Laboratory Medicine (CCLM), 2018
- New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)Autoimmunity Reviews, 2017
- Machine learning: Trends, perspectives, and prospectsScience, 2015
- Henoch–Schönlein purpura nephritis in childrenNature Reviews Nephrology, 2014
- EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisationAnnals of the Rheumatic Diseases, 2010
- EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaAnnals of the Rheumatic Diseases, 2010
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006